Form 8-K - Current report:
SEC Accession No. 0001558370-21-017078
Filing Date
2021-12-30
Accepted
2021-12-30 16:30:26
Documents
15
Period of Report
2021-12-23
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K omer-20211223x8k.htm   iXBRL 8-K 45992
2 EX-99.1 omer-20211223xex99d1.htm EX-99.1 14742
3 EX-99.2 omer-20211223xex99d2.htm EX-99.2 574939
4 GRAPHIC omer-20211223xex99d1001.jpg GRAPHIC 3542
  Complete submission text file 0001558370-21-017078.txt   791441

Data Files

Seq Description Document Type Size
5 EX-101.SCH omer-20211223.xsd EX-101.SCH 3273
6 EX-101.LAB omer-20211223_lab.xml EX-101.LAB 15369
7 EX-101.PRE omer-20211223_pre.xml EX-101.PRE 10400
9 EXTRACTED XBRL INSTANCE DOCUMENT omer-20211223x8k_htm.xml XML 4710
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

EIN.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34475 | Film No.: 211533180
SIC: 2834 Pharmaceutical Preparations